(Reuters) - More than 40 percent of patients with moderate to severe ulcerative colitis achieved clinical remission from the debilitating condition after a year of taking an experimental drug developed by Japan's Takeda Pharmaceutical Co, according to data from a pivotal late-stage trial.
Wednesday, 16 May 2012 | Source: The Associated Press
India's Piramal Healthcare said Wednesday it will buy Decision Resources Group, a U.S. healthcare information company, for 34 billion rupees ($635 million), as it slowly taps its cashpile for overseas acquisitions.
Tuesday, 8 May 2012 | Source: The Associated Press
Attorney General Mike DeWine says Ohio will get more than $10.7 million for its share of a settlement between dozens of states and Abbott Laboratories.
Tuesday, 8 May 2012 | Source: The Associated Press
Washington state will receive $7 million from multistate settlements with Abbott Laboratories over allegations the company illegally promoted an anti-seizure drug.
Rhode Island is set to receive more than $2.3 million from multistate settlements with Abbott Laboratories over allegations the company promoted the anti-seizure drug Depakote for uses that were not approved by the Food and Drug Administration.
The pharmaceuticals company agreed on Monday to pay $1.6 billion to resolve civil and criminal allegations related to past sales practices involving its anti-seizure drug Depakote.
Investors are reassured – and companies consider it a point of pride – when executives note an uninterrupted track record for raising dividends. Dividend payments also offer investors a cushion on their investment, increasing the overall returns of the stock. Historically, dividend payments have accounted for more than 40 percent of the S&P 500’s total returns.
The SPDR Health Care Select Sector exchange-traded fund is less than a sneeze from its recent highs, and some bulls are looking for it to pop.... Read More
Few stock sectors are as reliable as drugs and health care, and astute investors know that companies such as Merck, Pfizer, and Abbott Laboratories have delivered healthy returns over the years... Read More